Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 917.00
+1.00 (0.11%)
Nov 2, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 64.61 billion as of October 30, 2026. It is the 30,261st most valuable company in the world and the 1,583rd biggest in South Korea. Its market cap has decreased by 61.55% in one year.
Market Cap
64.61B
Enterprise Value
116.74B
Revenue
46.69B
Global Rank
Country Rank
#1,583 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 64.61B, a decrease of -72.76%. That is a compound annual growth rate of -9.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 64.61B | -34.71% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 151.77B |
| Anterogen.Co.,Ltd. | 133.68B |
| MedPacto | 104.54B |
| Genexine | 98.24B |
| Vaxcell-Bio Therapeutics | 86.63B |
| iNtRON Biotechnology | 86.19B |
| ENCell | 51.56B |
| GeneOne Life Science | 48.42B |